Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders.
Skin Health Dis. 2021 Mar 26;1(2):e22. doi: 10.1002/ski2.22. eCollection 2021 Jun.
Skin Health Dis. 2021.
PMID: 35664983
Free PMC article.
Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders.
Veit JGS, De Glas V, Balau B, Liu H, Bourlond F, Paller AS, Poumay Y, Diaz P.
Veit JGS, et al.
J Invest Dermatol. 2021 Jan;141(1):72-83.e6. doi: 10.1016/j.jid.2020.05.090. Epub 2020 Jun 4.
J Invest Dermatol. 2021.
PMID: 32505549
Free PMC article.
Review.
Item in Clipboard
Cite
Cite